BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25823896)

  • 1. Leukocyte mitochondrial DNA content: a novel biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Qu F; Chen Y; Wang X; He X; Ren T; Huang Q; Zhang J; Liu X; Guo X; Gu J; Xing J
    Carcinogenesis; 2015 May; 36(5):543-52. PubMed ID: 25823896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High leukocyte mtDNA content contributes to poor prognosis through ROS-mediated immunosuppression in hepatocellular carcinoma patients.
    He X; Qu F; Zhou F; Zhou X; Chen Y; Guo X; Li J; Huang Q; Yang Y; Lyu Z; Zhang H; Xing J
    Oncotarget; 2016 Apr; 7(16):22834-45. PubMed ID: 26985767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High leukocyte mitochondrial DNA content contributes to poor prognosis in glioma patients through its immunosuppressive effect.
    Chen Y; Zhang J; Huang X; Zhang J; Zhou X; Hu J; Li G; He S; Xing J
    Br J Cancer; 2015 Jun; 113(1):99-106. PubMed ID: 26022928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short telomere length in peripheral blood leukocyte predicts poor prognosis and indicates an immunosuppressive phenotype in gastric cancer patients.
    Qu F; Li R; He X; Li Q; Xie S; Gong L; Ji G; Lu J; Bao G
    Mol Oncol; 2015 Mar; 9(3):727-39. PubMed ID: 25515040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
    Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of mitochondrial DNA content and G10398A polymorphism in non-small cell lung cancer.
    Xu H; He W; Jiang HG; Zhao H; Peng XH; Wei YH; Wei JN; Xie CH; Liang C; Zhong YH; Zhang G; Deng D; Zhou YF; Zhou FX
    Oncol Rep; 2013 Dec; 30(6):3006-12. PubMed ID: 24101028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of mitochondrial mutations in colorectal cancer.
    Lièvre A; Chapusot C; Bouvier AM; Zinzindohoué F; Piard F; Roignot P; Arnould L; Beaune P; Faivre J; Laurent-Puig P
    J Clin Oncol; 2005 May; 23(15):3517-25. PubMed ID: 15908662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.
    Sugimachi K; Yokobori T; Iinuma H; Ueda M; Ueo H; Shinden Y; Eguchi H; Sudo T; Suzuki A; Maehara Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Oct; 21(11):3680-90. PubMed ID: 24217791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA polymorphisms, its copy number change and outcome in colorectal cancer.
    Mohideen AM; Dicks E; Parfrey P; Green R; Savas S
    BMC Res Notes; 2015 Jun; 8():272. PubMed ID: 26116242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
    Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
    Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short leukocyte telomere length predicts poor prognosis and indicates altered immune functions in colorectal cancer patients.
    Chen Y; Qu F; He X; Bao G; Liu X; Wan S; Xing J
    Ann Oncol; 2014 Apr; 25(4):869-876. PubMed ID: 24608194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA copy number in colorectal cancer: between tissue comparisons, clinicopathological characteristics and survival.
    van Osch FH; Voets AM; Schouten LJ; Gottschalk RW; Simons CC; van Engeland M; Lentjes MH; van den Brandt PA; Smeets HJ; Weijenberg MP
    Carcinogenesis; 2015 Dec; 36(12):1502-10. PubMed ID: 26476438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.
    Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
    Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
    Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
    Alexopoulou DK; Papadopoulos IN; Scorilas A
    Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients.
    Svoboda M; Slyskova J; Schneiderova M; Makovicky P; Bielik L; Levy M; Lipska L; Hemmelova B; Kala Z; Protivankova M; Vycital O; Liska V; Schwarzova L; Vodickova L; Vodicka P
    Carcinogenesis; 2014 Jul; 35(7):1510-5. PubMed ID: 24583926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between leukocyte mitochondrial DNA content and risk of coronary heart disease: a case-control study.
    Chen S; Xie X; Wang Y; Gao Y; Xie X; Yang J; Ye J
    Atherosclerosis; 2014 Nov; 237(1):220-6. PubMed ID: 25244506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
    Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
    Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
    J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability in the management of stage II colorectal patients.
    Strâmbu V; Garofil D; Pop F; Radu P; Brătucu M; Iorga C; Iorga R; Pasnicu C; Ion A; Popa F
    Chirurgia (Bucur); 2013; 108(6):816-21. PubMed ID: 24331320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.